# Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

> **NCT00298753** · PHASE4 · WITHDRAWN · sponsor: **Regional Hospital Holstebro**

## Conditions studied

- Syndrome of Inappropriate ADH-secretion

## Interventions

- **PROCEDURE:** fluid restriction for 14 days (15ml fluid per kg weight)

## Key facts

- **NCT ID:** NCT00298753
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no patients could be recruited
- **Last updated:** 2015-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298753, "Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00298753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*